Immunisation is not the same as a "CURE". The intention is to have the antigens in our bodies for us to create a "block" and dispel the awful virus before it can attack us. Herd immunity is ideal if can be achieved at 70% of populations.
Fundamental stocks are not the same as Speculative shares....and Dp is owned by LTAT, PNB and heavily invested by EPF. Don't believe as Government agencies, they would spew info into rumour mills to create speculative actions.
Although Government has placed orders for Pfizer vaccine to be delivered on quarterly basis. It's hard to see on basis of high demands on book-orders and current low production to have a single vial reaching our shores in 1Q 2021. Moreover, MOH has reiterated that all Vaccines should have FDA approval, NPRA certification, CTIL reviewed data and MTEC before being imported into the country and distributed into public. MOH has also implied that they should "wait and see" the response and reactions for the next 3-4 months, upon UK having the shots approved days ago.
Now, realise this, based on MOH stringent Control and Guidelines for vaccines and Drugs to be ALLOWED importation, and used on Public, would some other Vaccines be hitting the market soon? Especially those loudly advertised by some 10 sens companies, claiming to have signed MOU (not Agreement) purportedly to be distributing the Vaccines to some 600 million population of Asian regions (excluding China and India)????
Yes, certainly, the bottling fraternity may not be making huge and unimaginable profit margins as the inventors and manufacturing companies (holding copyrights too) Malaysia is too small a population of only 31 million to set up and start-up production plants which may cost tens of millions. However, Dp has been in this line for the past 20 over years with filling and distributing Insulin. New start ups would not be competitive and not viable as all beginnings the Cost Recovery period may take decades.
Yes, Dp cannot be compared with the giant pharmaceutical companies listed on Dow and priced at US$30 to above US$80 per share as Dp may just be US$1 here. However, the potential and prospect of Dp having a reasonable hand in the local markets, being under Government contracts should out-reach others.
We picked Pharmaniaga and Dp way back in March 2020, as a Vaccine is the most possible and probable way to contain the deadly virus. Pharma has been awarded the Government Contact the past 26 years as the Logistic, delivery and distributions channels to all hospitals. Their Contract expired in end 2019 and extended in Jan 2020 for 18 months. Ph may be the courier or postman, Dp would be a force to be involved in this tic-tac team for the Government, given that most medicine of Dp is for hospitals, govt and private as well as public pharmacies. As Govt has procured 20% from Pfizer and 10% under COVAX Agreement for the people, there still another 40-50% for herd immunity, if not more.
Also, given to understand that these vaccines are pre-packed and bottling may not be required. Having said that, the vials are not to be construed as a DIY item to be picked up at pharmacies and plunge into your arms, commando style. The storage, transportation, data registration and collections, coupled with the administration could only be in hospitals or Immunisation Centers allocated and approved by the Govt under MOH.
Yes Jonathan, you're seeing the whole picture now. Filling may not be required anymore. (except in another scenario) There are different stages and roles to be executed by different companies and healthcare administrators. All in, the Govt should be footing a lot of bills and paying much higher than the US$20 per bottle (maybe discount?) from Pfizer, if given FREE as announced (to front-line healthcare workers at the start) And from last week till this moment in the US, as preparation for mass vaccination, many Immunisation Centers has been put up and training for the nurses in handling of the vaccines (needs dilution in saline) to the actual injection is rolled out.
only people in medical line will understand ...this vaccine will be so controlled ...it will have real time tracking not all logistics or healthcare company will have the right to distribute
Yes, Param. But 10 sens counters claims to be vaccine distributors are hitting limits up. GLC counter, DP will have to wait their day and reap slowly. Nonetheless, Dp was only at RM1.55 in March and is now at RM4.00, can't complain.
Price at 4.00 is fairly valued. If the distribution and GLC are not factored in, it's a crime to be trading at PE of 51x. But would there be any opportunity for it to drop, say 5%, back to 3.80? We came in very much earlier in March-April, so it's nothing to worry. We shall evaluate the price in 4-6 weeks when REAL vaccination in USA, UK and other parts of the world has started.
Yes, good eyes Daw. EPF has been selling on those days when it hit 4.08 to 4.15 But who has been supporting at 4.00 levels now? If it drops by 5% to 3.80, we shall go hunting.
No wonder this share got dumped. We will understand how investors lost interest. Those others like Bintai and Solution will go crazy and smart people make good money.
ATA IMS Bhd, Duopharma Biotech Bhd, Heineken Malaysia Bhd, KLCCP Stapled, MR D.I.Y., Unisem (M) Bhd, UWC Bhd, and YTL Power International Bhd have been added to the FTSE Bursa Malaysia Mid 70 Index.
Withdrawal from EPF under I-Sinar account 1? Not so simple terms...many not eligible. Anyway, Oasischeah, the doomsayer says EPF selling DP EVERYDAY, where did he see that? Maybe care to share?
Here is the news of EPF sold the stock to prepare funding for I-sinar:
KUALA LUMPUR: Economists have brushed off claims that the Employees Provident Fund (EPF) has low cash reserves, thus compelling it to sell some of its assets to facilitate withdrawals for the i-Sinar programme.
I'm still baffled why there are so many nutcases being let out from Tanjung Rambutan. Really blew my casket. Covid-19 vaccines ARE ALL PRE-PACKED!!!!!!!! No need fill and finish.....period! It's the Govt Contract to handle Import and Distribution. That's the jewel. Phew!
dear colleague Dr Michael making a layman understand the cold chain cycle and how vaccine are so fragile is difficult that is why they are at bintai and solution.and some have filtered here
Since it has not moved, it has to come down. Being stagnant at 4.00 the past 2 weeks, it's time to test the support again. Discount 5% to 3.80? Loving it.
DUBAI: Bahrain said on Friday it has granted emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, becoming the second country after Britain to approve it.
The kingdom had also approved Sinopharm’s COVID-19 vaccine in November for use by frontline workers.
Not sure which is your entry price, Jon. This is really not a speculative counter where it jump leaps and bounds without foundations. The built-up has been long way back from above 2.30, 2.80, 3.20 then at 4.00. Twice breached 4.30 and pulled back. Failed the 4.15 many times. It's time to retest the support below 3.90 and hope it can re-test resistance at 4.20 But it would be a bad signal if it cannot.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DrMichael
266 posts
Posted by DrMichael > 2020-12-03 12:00 | Report Abuse
Immunisation is not the same as a "CURE". The intention is to have the antigens in our bodies for us to create a "block" and dispel the awful virus before it can attack us. Herd immunity is ideal if can be achieved at 70% of populations.